Risankizumab-Rzaa
Brand name: Skyrizi Pen
Rank #72 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$259.7M
Total Cost
12,539
Total Claims
$259.7M
Total Cost
709
Prescribers
$21K
Cost per Claim
639
Beneficiaries
31,084
30-Day Fills
$366K
Avg Cost/Provider
18
Avg Claims/Provider
Share of Medicare Part D Spending
0.09%
of total Medicare Part D spending
$259.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $259.7M total
🔎 Data Overview
At $20,709 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $366,256 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $406,378 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Risankizumab-Rzaa
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Brent Boyce | Dermatology | Sebewaing, MI | 123 | $2.5M |
| 2 | Kim Hinojosa | Nurse Practitioner | San Antonio, TX | 68 | $1.4M |
| 3 | Kevin Crawford | Dermatology | Seymour, IN | 59 | $1.3M |
| 4 | Jerald Hurdle | Interventional Pain Management | Waterville, ME | 59 | $1.3M |
| 5 | Hiram Ruiz Santiago | Dermatology | Bayamon, PR | 63 | $1.2M |
| 6 | Marti Rothe | Dermatology | Farmington, CT | 57 | $1.2M |
| 7 | Huachen Wei | Dermatology | Elmhurst, NY | 52 | $1.2M |
| 8 | David Cohen | Dermatology | Hewlett, NY | 54 | $1.2M |
| 9 | Pedro Vendrell | Dermatology | Ponce, PR | 57 | $1.1M |
| 10 | Monika Fischer | Gastroenterology | Indianapolis, IN | 53 | $1.1M |
| 11 | Laura Howe | Rheumatology | Greeley, CO | 50 | $1.0M |
| 12 | Aaron Wever | Dermatology | Concord, NC | 49 | $1.0M |
| 13 | Brian Gelb | Emergency Medicine | Petoskey, MI | 51 | $1.0M |
| 14 | Tanner Parrent | Dermatology | Hopkinsville, KY | 47 | $1.0M |
| 15 | June Kunapareddy | Dermatology | Terre Haute, IN | 45 | $970K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 69 | Elexacaftor/Tezacaftor/Ivacaft (Trikafta) | $269.3M | 9,821 |
| 70 | Immune Globul G/Gly/Iga Avg 46 (Gamunex-C) | $266.5M | 27,501 |
| 71 | Rosuvastatin Calcium (Rosuvastatin Calcium) | $264.9M | 11,259,701 |
| 72 | Risankizumab-Rzaa (Skyrizi Pen) | $259.7M | 12,539 |
| 73 | Venetoclax (Venclexta) | $259.6M | 28,191 |
| 74 | Zanubrutinib (Brukinsa) | $256.8M | 19,239 |
| 75 | Metoprolol Succinate (Metoprolol Succinate) | $256.3M | 12,847,535 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology